Neuphoria Therapeutics (NEUP) Goodwill (2020 - 2026)
Neuphoria Therapeutics (NEUP) posted quarterly Goodwill of $8.8 million for Q1 2026, up 4.64% year-over-year from $8.5 million in Q1 2025, and up 1.21% quarter-over-quarter from $8.7 million in Q4 2025.
Neuphoria Therapeutics (NEUP) Goodwill (2020 - 2026) Analysis & Trends
Neuphoria Therapeutics (NEUP) has reported Goodwill for 7 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill rose 4.64% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at $8.8 million (up 4.64% YoY), while the FY2025 annual figure was $8.6 million, down 0.59% from the prior year.
- Goodwill grew to $8.8 million in Q1 2026 per NEUP's latest filing, from $8.7 million in the prior quarter.
- Across five years, Goodwill topped out at $9.2 million in Q2 2022 and bottomed at $8.4 million in Q4 2024.
- Historically, Goodwill has averaged $8.7 million across 5 years, with a median of $8.7 million in 2024.
- Annual changes were most pronounced in 2023 — Goodwill decreased 5.12% — and 2026, when it grew 4.64%.
- Neuphoria Therapeutics' Goodwill stood at $9.2 million in 2022, then declined by 4.09% to $8.8 million in 2023, then slipped by 4.9% to $8.4 million in 2024, then climbed by 3.93% to $8.7 million in 2025, then grew by 1.21% to $8.8 million in 2026.
- Business Quant data shows NEUP's Goodwill at $8.8 million in Q1 2026, $8.7 million in Q4 2025, and $8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Neuphoria Therapeutics | 21.64 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.84 Mn |
| Dec 31, 2025 | 8.74 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 8.64 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Dec 31, 2024 | 8.41 Mn |
| Sep 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 8.69 Mn |
| Mar 31, 2024 | 8.63 Mn |
| Dec 31, 2023 | 8.84 Mn |
| Sep 30, 2023 | 8.57 Mn |
| Jun 30, 2023 | 8.75 Mn |
| Jun 30, 2022 | 9.22 Mn |
| Jun 30, 2021 | 9.55 Mn |
| Jun 30, 2020 | 8.44 Mn |